|
RTTN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64723790163634E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6991963391888E-12 |
| Normal-vs-Stage2 |
1.62458935193399E-12 |
| Normal-vs-Stage3 |
1.37134748001699E-12 |
| Normal-vs-Stage4 |
6.66133814775094E-15 |
| Stage1-vs-Stage2 |
6.883100E-03 |
| Stage1-vs-Stage3 |
7.094800E-01 |
| Stage1-vs-Stage4 |
1.287020E-01 |
| Stage2-vs-Stage3 |
1.014340E-02 |
| Stage2-vs-Stage4 |
2.822200E-01 |
| Stage3-vs-Stage4 |
1.241040E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67943436935047E-12 |
| Normal-vs-AfricanAmerican |
1.33769995080968E-10 |
| Normal-vs-Asian |
1.64249946976724E-10 |
| Caucasian-vs-AfricanAmerican |
7.387200E-01 |
| Caucasian-vs-Asian |
1.092830E-01 |
| AfricanAmerican-vs-Asian |
1.605620E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.65245594985208E-12 |
| Normal-vs-Female |
1.64923630308067E-12 |
| Male-vs-Female |
9.023200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.29785071578681E-13 |
| Normal-vs-Age(41-60Yrs) |
7.43849426498855E-15 |
| Normal-vs-Age(61-80Yrs) |
2.43305375846603E-12 |
| Normal-vs-Age(81-100Yrs) |
1.183160E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.021800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.731400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.494000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.092600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.633400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.342400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.673000E-01 |
| Classical-VS-Follicular |
2.49259999999252E-05 |
| Classical-VS-Other |
8.759200E-01 |
| Classical-VS-Normal |
3.18112203245846E-12 |
| Tall-VS-Follicular |
1.766360E-01 |
| Tall-VS-Other |
9.545800E-01 |
| Tall-VS-Normal |
2.91549999997809E-06 |
| Follicular-VS-Other |
2.742000E-01 |
| Follicular-VS-Normal |
4.44089209850063E-16 |
| Other-VS-Normal |
1.657170E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.10862446895044E-15 |
| Normal-vs-N1 |
1.75326420048805E-12 |
| N0-vs-N1 |
7.682600E-01 |
|
|
